2021 and 2022 attendees
2021 Delegate List
This event was run in person, with COVID restrictions
Job Title | Company |
Associate | Covington & Burling |
Business Leader | Puridify/Cytiva |
CBO | bit.bio |
CEO | Arecor Therapeutics Plc |
CEO | Arjuna Therapeutics |
CEO | Astrea Bioseparations |
CEO | Chain Biotechnology Ltd |
CEO | CN Bio Innovations |
CEO | Cytoseek |
CEO | Diurnal Group Plc |
CEO | Enesi Pharma |
CEO | Leaf Expression Systems Ltd |
CEO | LoQus23 and AstronauTx |
CEO | Medicines Discovery Catapult |
CEO | MicrofluidX Ltd |
CEO | NanoSyrinx Ltd |
CEO | NovaBiotics |
CEO | O2H |
CEO | PrecisionLife Ltd |
CEO | Prokarium Ltd |
CEO | Redx Pharma |
CEO | Scancell Ltd |
CEO | Theolytics |
CEO | Vaccitech Ltd |
CEO | Lightox |
CEO | DeepMatter Ltd |
CFO | AKL Research and Development Ltd |
Chairman | GSK |
Chairman and Managing Partner | Abingworth LLP |
Chief Business Officer | LifeArc |
Chief Business Officer | Medicines Discovery Catapult |
Co-founder | Migration Biotherapeutics |
Co-founder and CEO | Oxomics |
Co-Head of Healthcare team | Polar Capital |
Commercial Medicines Director | NHS England |
COO | Revolugen |
Executive Director, Head of Search & Evaluation/Region UK | Novartis |
Founder and CEO | eXmoor Pharma Concepts Ltd |
Founder and CEO | Oxford Immunotec |
GOSH-Institute of Child Health | UCL |
Head of Business & Operations | Alchemab |
Head of Business Development | Immunocore |
Head of Johnson & Johnson Innovation, EMEA | J&J |
Head of Sustainability | Polar Capital |
Interim CEO and Director | Angiodesign (UK) Ltd |
Managing Director | ICG |
Partner | Deloitte |
Principal, Head of Legal and Company Secretary | Oxford Science Innovation |
Professor of Experimental Hepatology | UCL |
Venture Partner | SV Health Investors |
2022 delegate list
Job title | Company |
Associate Director Business Development | LifeSci |
CEO | Congenica Ltd |
CEO | BIA |
CEO | Arjuna Therapeutics |
CEO | Theolytics Ltd |
CEO | Bitrobius Genetics Ltd |
CEO | OMass Therapeutics |
CEO | Cell and Gene Therapy Catapult |
CEO | Vaccitech Ltd |
CEO | MicrofluidX LTD |
CEO | Eagle Genomics Ltd |
CEO | F-star |
CEO | Ori Biotech |
CEO | MediSieve Limited |
CEO | PrecisionLife Ltd |
CEO | Revolugen |
CEO | Crescendo Biologics Ltd |
CEO | Complement Therapeutics |
CEO | Mestag Therapeutics Limited |
CEO | Enesi Pharma Ltd |
CEO | Arecor Limited |
CEO | Shellworks |
CEO | Curve Therapeutics |
CEO | Bit.Bio Ltd |
CEO | PsiOxus Therapeutics Ltd |
CEO | Reflection Therapeutics |
CEO | Ochre Bio Ltd |
CEO | Brainomix |
CEO | MarraBio |
CEO | CytoSeek Ltd |
CEO | AstronauTx Ltd |
CEO | Relation Therapeutics |
CEO | Leaf Expression Systems Limited |
CEO | Centauri Therapeutics Ltd |
CEO | Genenet Technology Limited |
CEO | O2h |
CEO | ATMPS Ltd |
CEO | MetalloBio |
CEO | In4Derm Ltd |
CEO | Agility Life Sciences |
CEO | BiologIC |
CEO | Angiodesign (UK) Ltd |
CEO | Lightox |
CEO & Co-founder | NanoSyrinx Ltd |
CEO & Executive Director | Stablepharma Ltd |
CEO and Founder | Creasallis |
CEO and founder | Mitra Bio |
Chair | AstronauTx Ltd |
Chief Business Officer | Medicines Discovery Catapult |
Chief Business Officer | Cancer Research UK |
Chief Executive | Kidney Research UK |
Chief Executive Officer | Therakind Ltd |
Chief Executive Officer | Chain Biotechnology Ltd |
Chief Executive Officer | Autifony Therapeutics Ltd |
Chief Executive Officer | Centauri Therapeutics Limited |
Chief Executive Officer & President | Astex Pharmaceuticals Ltd |
Chief Growth Officer | RBW Consulting |
Chief Operating Officer | BIA |
Co-Founder | NG Bio |
Co-founder | Trisk Bio |
Co-Founder & Chief Executive Officer | Sania Therapeutics |
COO | Iontas |
CSO | Synthace Ltd |
Director | Cytiva |
Director | ConsoneAI Ltd. |
Director of Business Development and Membership Services | BIA |
Director of External Affairs | BIA |
Director of International Outreach | Built with Biology |
Enterprise Account Executive | Elemental Machines |
Events Manager | BIA |
Events Manager | BIA |
Executive Assistant | BIA |
Executive Chairman | Congenica Ltd |
Executive Director, Search & Evaluation, NIBR BD&L | Novartis |
Founder and CEO | Extracellular Ltd |
Founder and CEO | eXmoor pharma concepts ltd. |
Founder, CEO | VasoDynamics Ltd |
Head of BD | LifeArc |
Head of J&J Innovation, EMEA | J&J |
Head of Marketing and Membership Communications | BIA |
Head of Membership | BIA |
Head of Policy and Public Affairs | BIA |
Head of UK Life Sciences | JLL |
Head of UK Site | Immunocore Limited |
Head of Ventures | Lifearc |
Interim CEO | Diurnal Group PLC |
Investment Director | UK Innovation & Science seed fund |
Lifesciences and Healthcare | Deloitte |
Managing Director | LifeSci |
Managing Director | Sixfold Bioscience Ltd |
Managing Director | EC M&A |
Managing Director UK | Avantor |
Partner | Taylor Wessing |
Partner | Taylor Wessing |
Partner | Mubadala |
Partner | Taylor Wessing |
Partner | Taylor Wessing |
Partner | Monitor Deloitte |
President | Real World Solutions, IQVIA |
President | Syneos One |
Programme Manager | BIA |
Regional Business Development Head | Diversio |
Research Associate | Stevens Group, Department of Materials, Imperial College London |
Senior Strategy Consultant | Monitor Deloitte |
Senior Vice President | Syneos Health |
Skills Strategy Consultant | BIA |
Strategy Manager | Deloitte |
SVP, Sales, BioPharma Production Solutions | Avantor |